Theratechnologies Net Debt vs Total Liab Analysis
TH Stock | CAD 1.71 0.02 1.16% |
Theratechnologies financial indicator trend analysis is much more than just breaking down Theratechnologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Theratechnologies is a good investment. Please check the relationship between Theratechnologies Net Debt and its Total Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.
Net Debt vs Total Liab
Net Debt vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Theratechnologies Net Debt account and Total Liab. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Theratechnologies' Net Debt and Total Liab is 0.92. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Total Liab in the same time period over historical financial statements of Theratechnologies, assuming nothing else is changed. The correlation between historical values of Theratechnologies' Net Debt and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Theratechnologies are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Net Debt i.e., Theratechnologies' Net Debt and Total Liab go up and down completely randomly.
Correlation Coefficient | 0.92 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from Theratechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Theratechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.At this time, Theratechnologies' Selling General Administrative is very stable compared to the past year. As of the 2nd of June 2024, Tax Provision is likely to grow to about 508.4 K, while Issuance Of Capital Stock is likely to drop about 16.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 53.8M | 62.1M | 71.4M | 75.0M | Total Revenue | 80.1M | 81.8M | 94.0M | 98.7M |
Theratechnologies fundamental ratios Correlations
Click cells to compare fundamentals
Theratechnologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Theratechnologies fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 100.1M | 119.2M | 93.3M | 77.8M | 89.4M | 65.2M | |
Short Long Term Debt Total | 50.7M | 55.4M | 56.7M | 66.7M | 76.7M | 80.6M | |
Total Current Liabilities | 41.9M | 45.1M | 114.3M | 47.3M | 54.4M | 57.1M | |
Total Stockholder Equity | 3.2M | 17.8M | (22.6M) | (20.9M) | (18.8M) | (17.8M) | |
Property Plant And Equipment Net | 3.5M | 2.9M | 3.1M | 2.0M | 1.8M | 1.3M | |
Net Debt | 42.6M | 36.3M | 42.9M | 23.9M | 27.5M | 28.8M | |
Retained Earnings | (300.1M) | (335.2M) | (382.6M) | (408.7M) | (367.8M) | (349.4M) | |
Accounts Payable | 17.5M | 15.5M | 12.9M | 7.0M | 8.0M | 6.4M | |
Cash | 12.7M | 20.4M | 23.9M | 34.1M | 39.2M | 41.2M | |
Non Current Assets Total | 35.3M | 27.3M | 19.9M | 14.5M | 16.6M | 29.9M | |
Non Currrent Assets Other | 17.1M | 12.2M | 621K | 1.8M | 1.6M | 1.5M | |
Cash And Short Term Investments | 40.6M | 20.8M | 40.4M | 33.1M | 38.0M | 20.2M | |
Net Receivables | 13.2M | 10.9M | 12.3M | 12.8M | 14.7M | 15.5M | |
Common Stock Shares Outstanding | 77.0M | 92.4M | 95.3M | 46.0M | 52.9M | 56.7M | |
Liabilities And Stockholders Equity | 117.6M | 100.1M | 119.2M | 93.3M | 107.2M | 62.9M | |
Non Current Liabilities Total | 55.0M | 56.4M | 1.6M | 51.3M | 59.0M | 62.0M | |
Inventory | 25.1M | 29.1M | 19.7M | 6.1M | 7.0M | 7.8M | |
Other Current Assets | 4.5M | 5.7M | 11.5M | 8.3M | 9.5M | 10.0M | |
Other Stockholder Equity | 15.2M | 16.5M | 17.3M | 20.9M | 18.8M | 17.9M | |
Total Liab | 96.9M | 101.5M | 115.8M | 98.6M | 113.4M | 119.1M | |
Property Plant And Equipment Gross | 3.5M | 3.6M | 3.9M | 3.2M | 2.9M | 3.0M | |
Total Current Assets | 64.8M | 91.9M | 73.4M | 63.3M | 72.8M | 76.4M | |
Accumulated Other Comprehensive Income | 21K | (481K) | (44K) | 385K | 442.8K | 464.9K | |
Short Term Debt | 20.6M | 425K | 463K | 65.3M | 75.1M | 78.8M | |
Intangible Assets | 31.9M | 23.8M | 15.0M | 12.5M | 14.4M | 12.3M | |
Other Current Liab | 23.9M | 58.1M | 36.1M | 1.5M | 1.7M | 1.6M | |
Short Term Investments | 8.0M | 20.0M | 9.2M | 6.3M | 5.7M | 9.9M | |
Current Deferred Revenue | 70K | 50K | 54K | 38K | 34.2K | 32.5K | |
Net Tangible Assets | (14.9M) | (28.6M) | (6.1M) | (37.6M) | (33.8M) | (32.1M) | |
Common Stock | 287.0M | 287.3M | 335.8M | 338.8M | 389.6M | 298.8M | |
Property Plant Equipment | 1.1M | 3.5M | 2.9M | 3.1M | 3.6M | 3.7M | |
Long Term Debt | 52.4M | 54.2M | 0.0 | 50.7M | 58.3M | 34.4M | |
Long Term Debt Total | 55.3M | 55.0M | 56.3M | 1.4M | 1.7M | 1.6M | |
Capital Surpluse | 10.8M | 12.1M | 12.8M | 18.8M | 21.6M | 12.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Theratechnologies Stock analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |